Current Issue February 2012, Vol. 6, No. 1

Issue Highlights

The effect of smoking on intestinal inflammation: What can be learned from animal models?
February 2012(Vol. 6 | No. 1 | Pages 1-12)
Stephanie Verschuere, Rebecca De Smet, Liesbeth Allais, Claude A. Cuvelier

Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases: TAFIa level in patients with IBD
February 2012(Vol. 6 | No. 1 | Pages 13-20)
Danuta Owczarek, Anetta Undas, Jonathan H. Foley, Michael E. Nesheim, Konrad Jabłonski, Tomasz Mach

Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease
February 2012(Vol. 6 | No. 1 | Pages 21-28)
Sandra Wenger, Susanna Nikolaus, Stefanie Howaldt, Bernd Bokemeyer, Andreas Sturm, Jan C. Preiss, Alain M. Schoepfer, Andreas Stallmach, Carsten Schmidt

On the zoonosis of M. avium subspecies paratuberculosis (MAP)
27 January 2012
Robert J. Greenstein, D. William Cameron, Sheldon T. Brown
As investigators who hypothesize that MAP is zoonotic, we read with considerable interest Dr. van Kruiningen's review contending that supportive data are flawed. We would like to address three regions...
Surgical management of gluteal metastatic cutaneous Crohn's disease
27 January 2012
Niamh Hogan, Valerie Byrnes, Alan Hussey, Myles Joyce
Abstract: Metastatic cutaneous Crohn's disease is a rare entity first described by McCallum et al. in 1976. It is diagnosed when histologically characteristic granulomata are seen at a site not contig...
Infliximab-induced psoriasis during therapy for Crohn's disease
27 January 2012
Flavio Steinwurz, Rafael Denadai, Rogério Saad-Hossne, Maria Luiza Queiroz, Fábio Vieira Teixeira, Ricardo Romiti
Abstract: Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-TNF-induced psoriasi...
Much is still to be learned about pathogenic Mycobacteria
24 January 2012
William M. Chamberlin
This letter is in response to the recent article by H. Van Kruiningen published in the JCC. In my opinion, Van Kruiningen's viewpoint is misleading. The association of Mycobacterium paratuberculosis (...
Exacerbation of Crohn's disease as paradoxical effect of infliximab
24 January 2012
Antonio Tursi, Alfredo Papa
Dear Sir,

View More Articles in Press...

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
February 2010 (Vol. 4 | No. 1 | Pages 28-62)
A. Dignass, G. Van Assche, J.O. Lindsay, M. Lémann, J. Söderholm, J.F. Colombel, S. Danese, A. D'Hoore, M. Gassull, F. Gomollón, D.W. Hommes, P. Michetti, C. O'Morain, T. Öresland, A. Windsor, E.F. Stange, S.P.L. Travis, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (609 KB)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
February 2010 (Vol. 4 | No. 1 | Pages 7-27)
Gert Van Assche, Axel Dignass, Julian Panes, Laurent Beaugerie, John Karagiannis, Mathieu Allez, Thomas Ochsenkühn, Tim Orchard, Gerhard Rogler, Edouard Louis, Limas Kupcinskas, Gerassimos Mantzaris, Simon Travis, Eduard Stange, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (364 KB)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
March 2008 (Vol. 2 | No. 1 | Pages 1-23)
E.F. Stange, S.P.L. Travis, S. Vermeire, W. Reinisch, K. Geboes, A. Barakauskiene, R. Feakins, J.F. Fléjou, H. Herfarth, D.W. Hommes, L. Kupcinskas, P.L. Lakatos, G.J. Mantzaris, S. Schreiber, V. Villanacci, B.F. Warren, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (471 KB)
European evidence-based Consensus on the management of ulcerative colitis: Current management
March 2008 (Vol. 2 | No. 1 | Pages 24-62)
S.P.L. Travis, E.F. Stange, M. Lémann, T. Øresland, W.A. Bemelman, Y. Chowers, J.F. Colombel, G. D'Haens, S. Ghosh, P. Marteau, W. Kruis, N.J.McC. Mortensen, F. Penninckx, M. Gassull, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (587 KB)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
February 2010 (Vol. 4 | No. 1 | Pages 63-101)
Gert Van Assche, Axel Dignass, Walter Reinisch, C. Janneke van der Woude, Andreas Sturm, Martine De Vos, Mario Guslandi, Bas Oldenburg, Iris Dotan, Philippe Marteau, Alessandro Ardizzone, Daniel C. Baumgart, Geert D'Haens, Paolo Gionchetti, Francisco Portela, Boris Vucelic, Johan Söderholm, Johanna Escher, Sibylle Koletzko, Kaija-Leena Kolho, Milan Lukas, Christian Mottet, Herbert Tilg, Séverine Vermeire, Frank Carbonnel, Andrew Cole, Gottfried Novacek, Max Reinshagen, Epameinondas Tsianos, Klaus Herrlinger, Bas Oldenburg, Yoram Bouhnik, Ralf Kiesslich, Eduard Stange, Simon Travis, James Lindsay, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (607 KB)

On the Cover

New Issue Alert

Free Trial Issue

See our companion journal, Journal of Crohn's and Colitis Supplements also published by Elsevier.

ECCO Information

The mission of the European Crohn's and Colitis Organisation (ECCO) is to strive for optimized care for patients with inflammatory bowel diseases (IBD) in all aspects. To this end, ECCO will adopt and further all efforts that lead to an improvement in the use of current therapies and procedures, develop guidelines with the highest possible process and content quality, and define better and more valid outcome parameters for the therapy of IBD. In addition, ECCO promotes the specialist, postgraduate education in IBD and scientific projects in IBD.

Access this journal onSciVerse ScienceDirect

About CROHNS

The Journal of Crohn's and Colitis is the official journal of the European Crohn's and Colitis Organisation (ECCO) and is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to inflammatory bowel diseases. The journal publishes original articles, review papers, editorials, leading articles, viewpoints, case reports, innovative methods and letters to the editor. All submitted material is subject to a peer-review process. Supplemental issues of the journal are published under a separate title, Journal of Crohn's and Colitis Supplements.

Journal Access

Access to abstracts is complimentary. Access to full text is limited to print subscribers.

Members of the European Crohn's and Colitis Organisation (ECCO) receive a subscription to the Journal of Crohn's and Colitis as part of their membership benefits. To become a member of ECCO, please visit the ECCO website.

Activate Online Access

Journal Ranking

Impact Factor of this journal
2010 impact factor: 2.628
© Journal Citation Reports 2011, published by Thomson Reuters

Publishing Information

The Journal of Crohn's and Colitis is published for the European Crohn's and Colitis Organisation (ECCO) by Elsevier.